XTL Biopharmaceuticals Ltd. focuses on the acquisition and development of pharmaceutical products for the treatment of unmet clinical needs. XTL is a public
Investors 1
| Date | Name | Website |
| - | Israel Hea... | ihcv.co.il... |
Mentions in press and media 1
| Date | Title | Description |
| 17.12.2021 | XTL Biopharmaceuticals : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON JANUARY 19, 2022 - Form 6-K | NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON JANUARY 19, 2022 To the shareholders of XTL Biopharmaceuticals Ltd.: Notice is hereby given that an Annual General Meeting (the "Annual Meeting") of the shareholders o... |